mark t hamann
Medical University of South Carolina
Charleston, United States
Associate Editor
Anti-Infective Agents
Medical University of South Carolina
Charleston, United States
Associate Editor
Anti-Infective Agents
Kasetsart University
Bangkok, Thailand
Associate Editor
In silico Methods and Artificial Intelligence for Drug Discovery
University of Helsinki
Helsinki, Finland
Associate Editor
Anti-Infective Agents
National Institute of Cancerology (INCAN)
Mexico City, Mexico
Associate Editor
Anti-Cancer Drugs
Department of Pharmacology and Toxicology, College of Pharmacy, The University of Utah
Salt Lake City, United States
Associate Editor
Cardiovascular and Hematologic Drugs
UMR7140 Chimie de la Matière Complexe
Strasbourg, France
Associate Editor
In silico Methods and Artificial Intelligence for Drug Discovery
Black Diamond Therapeutics, Inc
Cambridge, United States
Associate Editor
Technologies and Strategies to Enable Drug Discovery
College of Dentistry, New York University
New York, United States
Associate Editor
Neurological Drugs
University of the Western Cape
Bellville, South Africa
Associate Editor
Neurological Drugs
University of Rajshahi
Rajshahi, Bangladesh
Associate Editor
Anti-Cancer Drugs
Columbia University
New York City, United States
Associate Editor
Dermatologic Drugs
Johns Hopkins University
Baltimore, United States
Associate Editor
Cardiovascular and Hematologic Drugs
University Hospital Hradec Kralove
Hradec Králové, Czechia
Associate Editor
Neurological Drugs
College of Medicine, Drexel University
Philadelphia, United States
Associate Editor
Neurological Drugs
University of Missouri
Columbia, United States
Associate Editor
Neurological Drugs
Basque Center for Materials, Applications and Nanostructures
Leioa, Spain
Associate Editor
In silico Methods and Artificial Intelligence for Drug Discovery